» Articles » PMID: 37113916

Dual Insulin Resistance Causes: How Frequently Type 2 Diabetes Mellitus and COVID-19 Infection Caused Diabetic Ketoacidosis? a Case Report

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2023 Apr 28
PMID 37113916
Authors
Affiliations
Soon will be listed here.
Abstract

Case Presentation: A 61-year-old retired Black African female was taken into the emergency room on 22 April 2022, with significant complaints of frequent midnight urination, shortness of breath, blurry vision, and tingling in her hands and feet. On a chest radiography, bilateral diffuse, patchy airspace opacities that might be due to multifocal pneumonia or viral pneumonia were seen. The severe acute respiratory syndrome infection was confirmed by real-time reverse transcription-PCR testing from nasopharyngeal swabs. She received intravenous fluids and an intravenous insulin infusion and monitored her blood electrolyte levels as part of her treatment. She received subcutaneous enoxaparin 80 mg every 12 h a day for prophylaxis of deep venous thrombosis due to her confirmed COVID-19.

Clinical Discussion: In a large number of patients, COVID-19 has the ability to trigger DKA, and type 2 diabetes mellitus amplifies the underlying COVID-19 infection. Diabetes mellitus and COVID-19 are noted to have a reciprocal relationship in this regard.

Conclusions: By making the body resistant to insulin and raising blood sugar levels, a COVID-19 infection can cause DKA. It is probable that her severe acute respiratory syndrome coronavirus 2 infection has a detrimental effect on the pancreatic beta cells, which are responsible for her body producing insufficient levels of insulin.

Citing Articles

COVID-19 is associated with high blood glucose levels: diabetic neuropathy during the SARS-CoV-2 pandemic: a case report.

Bereda G Ann Med Surg (Lond). 2024; 86(12):7318-7321.

PMID: 39649935 PMC: 11623843. DOI: 10.1097/MS9.0000000000000990.


Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood Donors.

Alqahtani T, Ali Alghamdi M, Baig M, Al-Abbasi F, Sheikh R, Almalki N Curr Diabetes Rev. 2024; 20(9):e110124225520.

PMID: 38415496 DOI: 10.2174/0115733998274390231110050809.


Prevalence and risk factors of COVID-19 infection, mortality, and post-infection lung fibrosis in patients with type 2 diabetes: a cross-sectional study.

Farah R, Al-Hawari H, Albtoush A, Nofal A, Hyasat T, Abu Jabeh R J Int Med Res. 2023; 51(9):3000605231198413.

PMID: 37728611 PMC: 10515529. DOI: 10.1177/03000605231198413.


Renal function impairment might be worsened by SARS-CoV-2 virus: a triple critical care disease causing hypoxemia.

Bereda G Ann Med Surg (Lond). 2023; 85(7):3670-3673.

PMID: 37427226 PMC: 10328694. DOI: 10.1097/MS9.0000000000000910.


How is ischemic stroke linked to a COVID-19-infected patient different from other cardiovascular risk factors? a case report.

Bereda G Ann Med Surg (Lond). 2023; 85(6):2995-2998.

PMID: 37363457 PMC: 10289628. DOI: 10.1097/MS9.0000000000000661.


References
1.
Zhang X, Qin J, Cheng X, Shen L, Zhao Y, Yuan Y . In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. Cell Metab. 2020; 32(2):176-187.e4. PMC: 7311917. DOI: 10.1016/j.cmet.2020.06.015. View

2.
Aberer F, Hochfellner D, Sourij H, Mader J . A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital. J Clin Med. 2021; 10(10). PMC: 8157052. DOI: 10.3390/jcm10102154. View

3.
Sharma S, Ray A, Sadasivam B . Metformin in COVID-19: A possible role beyond diabetes. Diabetes Res Clin Pract. 2020; 164:108183. PMC: 7190487. DOI: 10.1016/j.diabres.2020.108183. View

4.
Apicella M, Campopiano M, Mantuano M, Mazoni L, Coppelli A, Del Prato S . COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020; 8(9):782-792. PMC: 7367664. DOI: 10.1016/S2213-8587(20)30238-2. View

5.
Kusuma Boddu S, Aurangabadkar G, Kuchay M . New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2021; 14(6):2211-2217. PMC: 7669477. DOI: 10.1016/j.dsx.2020.11.012. View